This message was sent to ##Email##
|
|
|
|
|
|
As 2017 comes to a close, SCAI would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of SCAI This Week a look at the most accessed articles from the year. Our regular publication will resume Thursday, Jan. 4.
|
TCTMD
From Sept. 8: Abbott Vascular is calling a halt to sales of the Absorb bioresorbable vascular scaffold as of Sept. 14, attributing the decision to "low commercial sales."
"We pioneered bioresorbable technology because we believe it offers patients the possibility of life without permanent metallic implants, and we will continue work on a next-generation bioresorbable device," the company announced on its website.
READ MORE
TCTMD
From Aug. 3: There’s more evidence that routine exposure to radiation in the cath lab can put interventional cardiologists at increased risk for cataracts. Investigators say the findings highlight the importance of using protective shields and wearing lead glasses.
The meta-analysis, published in the July 2017 issue of Catheterization and Cardiovascular Interventions, also suggests that technical staff in the cath lab who are exposed to occupational ionizing radiation may be more susceptible to a certain type of cataract than unexposed controls.
READ MORE
TCTMD
From July 6: Intracoronary infusion of a room temperature solution during primary PCI achieves its goal of hemodilution safely, preliminary research suggests, but larger studies are required to show whether the approach can lessen reperfusion injury.
In 10 patients with STEMI, the technique resulted in a drop in intracoronary temperature by a median of 3.4 degrees Celcius, an indirect sign that hemodilution was successful, according to lead author Michael McGarvey, MD, and colleagues.
READ MORE
|
Promoted by
|
|
|
|
 |
MedPage Today
From Feb. 23: A less costly and safer pathway for percutaneous coronary intervention (PCI) may require just two changes: a "radial first" strategy coupled with same-day discharge, a study suggested. "I would bet that future analyses looking at PCI data for 2017 will demonstrate that we have innovated even further in the transradial space such that we have found ways to tackle more complex cases, sicker patients and improved our processes to mobilize transradial patients home faster," commented Chandan M. Devireddy, M.D., of Atlanta's Emory University Hospital Midtown, who was not a part of the study.
READ MORE
|
|
By Sridevi R. Pitta, M.D., MBA, FSCAI, and Rahul Sharma, M.D.
From Jan. 26: Transradial catheterization is associated with a marked reduction in access site bleeding compared with transfemoral access. However, transradial arterial catheterization can result in unique challenges and complications. The most commonly encountered challenge is radial artery spasm which occurs with a frequency of 15-30 percent and ranges from mild to severe.
In this tip of the month, we make the radial operator aware of techniques which have proven effective in the management of an entrapped radial sheath or catheter and highlight a stepwise approach to overcome this complication.
Read the January Tip of the Month here.
Advertisement
Pulsara
St. Elizabeth Healthcare, in Edgewood, Kentucky, serves a population of more than 400,000 across the Greater Cincinnati area, from Northern Kentucky to Indiana and Ohio. At St. Elizabeth, like most health systems in the U.S., there was no overarching way to organize all the different cardiac team members and stakeholders, which could cause treatment delays and disorganization. After adopting a set of recommended changes in the process of responding to heart attack patients including the implementation of Pulsara, the time from first medical contact to the moment of artery-opening treatment dropped 30 percent. See the full story here.
READ MORE
|
SCAI
From May 19: SCAI and the Heart Failure Society of America (HFSA) have released a new consensus document detailing the clinical utility of invasive hemodynamics in current cardiovascular practices. The document, "SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease," provides insight into the pathophysiology of the heart and circulatory system through detailed invasive hemodynamic studies performed in the cardiac catheterization laboratory.
View the expert consensus document here.
Healio
From June 1: The use of a microcatheter to perform factional flow reserve after stenting may help clinicians optimize percutaneous coronary intervention (PCI) procedures and predict poststenting clinical outcomes, according to data presented at EuroPCR.
Roberto Diletti, MD, PhD, interventional cardiologist at Thoraxcenter of the Erasmus Medical Center in Rotterdam, the Netherlands, and colleagues conducted FFR-SEARCH, a prospective registry study of 1,000 patients with 1,348 lesions who underwent successful PCI and had FFR measured with a microcatheter (Navvus, Acist Medical) after the procedure.
READ MORE
 |
|
Resolute Onyx™ DES is the next great advance in DES performance. Combining two powerful stent technologies — Continuous Sinusoid Technology and Core Wire Technology — Resolute Onyx™ DES offers exceptional deliverability, enhanced visibility, and the first 4.5- and 5.0-mm
DES sizes. Learn more at resoluteonyx.com ISW
© 2017 Medtronic. UC201802492EN
|
|
SCAI
From Nov. 2: This year, SCAI celebrated the 40-year anniversary of a groundbreaking procedure, now known as percutaneous coronary intervention (PCI), that has saved millions of lives and enhanced the lives of millions more. Four decades of clinical study have confirmed the benefit of PCI for patients with myocardial ischemia (insufficient blood flow to an area of heart muscle). A new study presented today at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 scientific symposium in Denver questions the value of this revolutionary procedure in some patients.
Read the full press release here.
|
|
SCAI via Medical Xpress
From Aug. 17: A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivalirudin doses on net adverse clinical events and mortality. Patients recovering from PCI with bivalirudin are at a lower risk of bleeding, but also suffer an increased risk of acute stent thrombosis.
READ MORE
Healio
From March 2: "Telestenting," which involves a combination of telecommunications and a robotic system for percutaneous coronary intervention (PCI), may one day allow interventional cardiologists to perform stenting remotely.
In REMOTE-PCI, a single-center, prospective, observational study, researchers sought to determine whether physician operators were capable of performing robotic PCI from a physical location separate from the patient.
READ MORE
| Date |
Event |
Location |
| Jan. 24, 2018 |
SCAI FIRST January 2018 (Fellows' Interventional Regional Shared Training): CHIP: A Patient-Centered, Case-Based Discussion |
Boston, MA
|
| Feb. 3-7, 2018 |
International Symposium on Endovascular Therapy (ISET) 2018 |
Hollywood, FL
|
| Feb. 8-9, 2018 |
SCRIPPS Seventh Annual Structural Heart Intervention and Imaging: A Practical Approach |
La Jolla, CA
|
| Feb. 9-10, 2018 |
International Symposium on Left Atrial Appendage (ISLAA) 2018 |
Long Beach, CA
|
| Feb. 22-24, 2018 |
Cardiovascular Summit: Contemporary Strategies for Quality Improvement, Operational Excellence, Finance and Leadership |
Las Vegas, NV
|
| March 21-24, 2018 |
Scottsdale Interventional Forum (SIF) |
Scottsdale, AZ
|
| April 25-28, 2018 |
SCAI 2018 Scientific Sessions |
San Diego, CA
|
For a complete list of job postings, click here.
To post your resume, click here.
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
